ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2020 American Transplant Congress

    Operational Tolerance in Kidney Transplant Recipients: Tomogram Transcriptomic Study

    O. Viklicky1, J. Klema2, P. Mrazova1, D. Abramowitz3, M. Abramowicz4, A. Massart3, P. Hruba1

    1Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 2Czech Technical University, Prague, Czech Republic, 3Antwerp University Hospital, Antwerp, Belgium, 4Université Libre de Bruxelles, Brussels, Belgium

    *Purpose: TOMOGRAM is a European multicenter study, that aims to identify transcriptomic and genomic signatures of operational tolerance (OT) in a recently identified cohort of…
  • 2020 American Transplant Congress

    Single Dose Rituximab and Anti-Thymocyte Globulin (ATG) Induction in Hypersensitized Kidney Transplant Recipients

    A. X. Wang, U. Wang, S. Busque, C. R. Lenihan

    Stanford University School of Medicine, Stanford, CA

    *Purpose: Hypersensitized kidney transplant recipients (calculated panel reactive antibody (cPRA) ≥98%) may represent a population at high risk of posttransplant immunologic events. While access to…
  • 2020 American Transplant Congress

    Association of Congenital Anomalies of the Kidney and Urinary Tract with Urinary Tract Infection and Graft Rejection in Pediatric Kidney Transplant Recipients

    M. Bock, D. Han, A. Sikora, K. Mckinnon, S. Hecht, M. Chandran, V. Vemulakonda

    Children's Hospital Colorado, Denver, CO

    *Purpose: Congenital anomalies of the kidney and urinary tract (CAKUT) are a leading cause of pediatric end-stage renal disease (ESRD). Prior studies have shown an…
  • 2020 American Transplant Congress

    Torque Teno Virus Level for Risk Stratification of Subclinical Graft Rejection at 12 Months after Kidney Transplantation – An Prospective Observational Cohort Study

    K. Doberer, E. Puchhammer, G. Böhmig, G. Bond

    Medical University Vienna, Vienna, Austria

    *Purpose: Non-invasive monitoring strategies are insufficient to detect patients at risk for subclinical graft rejection after kidney transplantation. The highly prevalent and non-pathogenic Torque Teno…
  • 2020 American Transplant Congress

    Routine Human Renal Allograft Biopsies Analyzed for mRNA Content with a Novel Nanostring mRNA Human Organ Transplant (HOT) Panel

    I. Rosales1, R. Smith1, E. Acheampong1, T. Kawai1, T. Tsuji2, K. Hotta3, R. Colvin1

    1Massachusetts General Hospital, Boston, MA, 2Sapporo City General Hospital, Sapporo, Japan, 3Hokkaido University Hospital, Sapporo, Japan

    *Purpose: In 2019 a Banff Working Group and Nanostring Technologies developed a panel of 770 mRNA probes for assessment of human organ allografts, based on…
  • 2020 American Transplant Congress

    CD38 Antibody Daratumumab for the Treatment of Chronic Antibody-Mediated Kidney Allograft Rejection

    K. Doberer1, J. Kläger2, G. A. Gualdoni1, K. Mayer1, F. Eskandary1, H. Agis3, T. Reiter1, R. Reindl-Schwaighofer1, M. Wahrmann1, G. Cohen1, H. Haslacher4, G. Bond1, I. Simonitsch-Klupp5, I. Farkash6, P. Halloran7, G. A. Böhmig1

    1Department of Medicine III, Medical University of Vienna, Vienna, Austria, 2Dept. of Clin. Pathology, Medical University of Vienna, Vienna, Austria, 3Department of Medicine I, Medical University of Vienna, Vienna, Austria, 4Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria, 5Department of Pathology, Medical University of Vienna, Vienna, Austria, 6Dept. of Pathology, University of Michigan, Ann Arbor, MI, 7Alberta Transplant Applied Genomics Centre, ATAGC, University of Alberta, Edmonton, AB, Canada

    *Purpose: Late antibody-mediated rejection (ABMR) is a major cause of transplant failure. Potential therapeutic targets are plasma cells (PC) and natural killer (NK) cells expressing…
  • 2020 American Transplant Congress

    Five Year Patient Important Outcomes of Treated Acute Rejections Diagnosed with Protocol and Clinical Biopsy after Pancreas Transplant Alone for Type 1 Diabetes

    Y. C. Kudva, S. R. Rizvi, R. Kaur, B. H. Smith, S. Batthula, P. G. Dean, A. Kukla, W. K. Kremers, M. D. Stegall

    Mayo Clinic, Rochester, MN

    *Purpose: STUDY PURPOSE: Acute rejection (AR) after Pancreas Transplant alone (PTA) continues to be a significant morbidity. We compared the outcomes of PTA recipients treated…
  • 2020 American Transplant Congress

    Anti-T Lymphocyte Immunoglobulins versus Basiliximab in Highly Sensitized Kidney-Transplant Patients without Preformed DSAs: The Satir Study

    N. Kamar1, L. Couzi2, L. Albano3, A. Durrbach4, V. Pernin5, L. Esposito1, M. Lequintrec5, P. Merville2, A. Del Bello1

    1Toulouse University Hospital, Toulouse, France, 2Bordeaux University Hospital, Bordeaux, France, 3Nice University Hospital, Nice, France, 4Henri Mondor University Hospital, Paris, France, 5Montpellier University Hospital, Montpellier, France

    *Purpose: Two prospective studies that were performed before the era of highly sensitive solid-phase assays have shown a lower incidence of acute rejection in highly…
  • 2020 American Transplant Congress

    Single Center Experience Using Low-Dose Antithymocycte Globulin for Induction Following Heart Transplant

    T. J. ONeill IV, G. Jao, A. Kelkar, B. Pisani

    Wake Forest Baptist Health System, Winston Salem, NC

    *Purpose: The use of induction therapy after cardiac transplantation remains highly variable, not only in terms of which agent is used, but whether it is…
  • 2020 American Transplant Congress

    Inflammatory Cytokines Have a Different Effect from One HLA-II Subclass to Another on Human Endothelium

    S. Beland, F. Bouchard-Boivin, A. Gama, O. Desy, S. A. De Serres

    Universite Laval, Quebec, QC, Canada

    *Purpose: Development of de novo donor-specific antibodies (DSAs) is associated with antibody-mediated rejection and allograft failure. More particularly, HLA-II DSAs, especially those against DQ are…
  • « Previous Page
  • 1
  • …
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences